These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38367368)
1. Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains. Painter H; Willcocks S; Zelmer A; Reljic R; Tanner R; Fletcher H Tuberculosis (Edinb); 2024 May; 146():102494. PubMed ID: 38367368 [TBL] [Abstract][Full Text] [Related]
2. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis. Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524 [TBL] [Abstract][Full Text] [Related]
3. Lee H; Kim J; Kang YA; Kim DR; Sim B; Zelmer A; Fletcher HA; Dockrell HM; Smith SG; Cho SN Front Immunol; 2019; 10():896. PubMed ID: 31105706 [No Abstract] [Full Text] [Related]
4. Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: Tanner R; Satti I; Harris SA; O'Shea MK; Cizmeci D; O'Connor D; Chomka A; Matsumiya M; Wittenberg R; Minassian AM; Meyer J; Fletcher HA; McShane H Front Immunol; 2019; 10():2983. PubMed ID: 31998295 [TBL] [Abstract][Full Text] [Related]
5. Development and application of the direct mycobacterial growth inhibition assay: a systematic review. Painter H; Harriss E; Fletcher HA; McShane H; Tanner R Front Immunol; 2024; 15():1355983. PubMed ID: 38380319 [TBL] [Abstract][Full Text] [Related]
7. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans. Prabowo SA; Smith SG; Seifert K; Fletcher HA Tuberculosis (Edinb); 2019 Dec; 119():101876. PubMed ID: 31698310 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb). Marsay L; Matsumiya M; Tanner R; Poyntz H; Griffiths KL; Stylianou E; Marsh PD; Williams A; Sharpe S; Fletcher H; McShane H Tuberculosis (Edinb); 2013 Sep; 93(5):551-7. PubMed ID: 23726784 [TBL] [Abstract][Full Text] [Related]
15. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
16. A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system. Yang AL; Schmidt TE; Stibitz S; Derrick SC; Morris SL; Parra M J Microbiol Methods; 2016 Dec; 131():7-9. PubMed ID: 27650198 [TBL] [Abstract][Full Text] [Related]
17. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
18. Radloff J; Heyckendorf J; van der Merwe L; Sanchez Carballo P; Reiling N; Richter E; Lange C; Kalsdorf B Front Immunol; 2018; 9():1708. PubMed ID: 30087678 [TBL] [Abstract][Full Text] [Related]
19. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy. Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843 [TBL] [Abstract][Full Text] [Related]
20. Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis. Jensen C; Lindebo Holm L; Svensson E; Aagaard C; Ruhwald M Sci Rep; 2017 Jun; 7(1):2830. PubMed ID: 28588268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]